Details for New Drug Application (NDA): 011909
✉ Email this page to a colleague
NDA 011909 describes NARDIL, which is a drug marketed by Parke Davis and is included in one NDA. It is available from two suppliers. Additional details are available on the NARDIL profile page.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
Summary for 011909
| Tradename: | NARDIL |
| Applicant: | Parke Davis |
| Ingredient: | phenelzine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 011909
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 011909
Suppliers and Packaging for NDA: 011909
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NARDIL | phenelzine sulfate | TABLET;ORAL | 011909 | NDA | Parke-Davis Div of Pfizer Inc | 0071-0350 | 0071-0350-60 | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60) |
| NARDIL | phenelzine sulfate | TABLET;ORAL | 011909 | NDA AUTHORIZED GENERIC | Greenstone LLC | 59762-0119 | 59762-0119-1 | 60 TABLET, FILM COATED in 1 BOTTLE (59762-0119-1) |
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 15MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
